ID: ALA5276767

Max Phase: Preclinical

Molecular Formula: C21H17N5O6S

Molecular Weight: 467.46

Associated Items:

Representations

Canonical SMILES:  O=C1/C(=N\Nc2ccc(S(=O)(=O)O)cc2)C(c2ccc([N+](=O)[O-])cc2)NN1c1ccccc1

Standard InChI:  InChI=1S/C21H17N5O6S/c27-21-20(23-22-15-8-12-18(13-9-15)33(30,31)32)19(14-6-10-17(11-7-14)26(28)29)24-25(21)16-4-2-1-3-5-16/h1-13,19,22,24H,(H,30,31,32)/b23-20-

Standard InChI Key:  NYWRCTGUUZWRDE-ATJXCDBQSA-N

Associated Targets(Human)

Protein-tyrosine phosphatase 2C 2297 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Protein-tyrosine phosphatase 1C 687 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Protein-tyrosine phosphatase 1B 8528 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 467.46Molecular Weight (Monoisotopic): 467.0900AlogP: 2.90#Rotatable Bonds: 6
Polar Surface Area: 154.24Molecular Species: ACIDHBA: 8HBD: 3
#RO5 Violations: 0HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: -2.43CX Basic pKa: CX LogP: 2.11CX LogD: 0.30
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.28Np Likeness Score: -1.07

References

1. Zhang J, Zhang Y, Qu B, Yang H, Hu S, Dong X..  (2021)  If small molecules immunotherapy comes, can the prime be far behind?,  218  [PMID:33773287] [10.1016/j.ejmech.2021.113356]

Source